Drug Trial Radar · NCT03622047
Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil
Last checked: Nov 20, 2026Latest source record: Feb 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,800
Planned (sponsor's estimate)
Start
Aug 15, 2018
Primary completion
Aug 1, 2020
Study completion Aug 1, 2020
Sponsor
- Lead sponsor
- Fudan UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Jiaxing University Affiliated Women and Children Hospital; Shanghai First Maternity and Infant Hospital
- First posted
- Aug 9, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 22 years, up to 42 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The participants: 1800 full-term primiparas will be selected with ASA I-Ⅱgrade, 20 to 35 years old and weighing 55 to 90 kg in the investigator's hospital from may 2018 to December 2018. 1200 primiparas were divided into A and B according to the computer randomized numbers, and 600 parturients without labor analgesia in the same period were selected as group C, with 600 patients in each group. All parturients signed the informed consent form and were approved by the hospital ethics Committee.
Conditions
- Pharmacological Action
Interventions
Dexmedetomidine ropivacaineDrug
Observing the effect of 0.5 μ g / ml sufentanil+ 0.1 % ropivacaine with 2 hours after fetal delivery, and the patients leave the delivery room without abnormality.
No analgesia laborDrug
No analgesia labor control group
Primary outcomes
What the sponsor says the trial is designed to measure.
- The onset timeTime frame: 30 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
International Peace Maternity and Child Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.